How does P-glycoprotein recognize its substrates ?UEDA, K; TAGUCHI, Y; MORISHIMA, M et al.Seminars in cancer biology. 1997, Vol 8, Num 3, pp 151-159, issn 1044-579XArticle

Study of P-Glycoprotein Functionality in Living Resistant K562 Cells After Photolabeling with a Verapamil AnalogueMANKHETKORN, S; TEODORI, E; SCAPECCHI, S et al.Biochemical pharmacology. 1996, Vol 52, Num 2, pp 213-218, issn 0006-2952, 5 p.Article

Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemiaDEL POETA, G; STASI, R; PAPA, G et al.Blood. 1996, Vol 87, Num 5, pp 1997-2004, issn 0006-4971Article

Studies of multidrug transport proteins in cells derived from human lung samplesBAGRIJ, T; HLADKY, S. B; STEWART, S et al.International journal of clinical pharmacology and therapeutics. 1998, Vol 36, Num 2, pp 80-81, issn 0946-1965Conference Paper

Multidrug resistance : molecular and clinical aspectsDICATO, M; DUHEM, C; PAULY, M et al.Cytokines, cellular & molecular therapy. 1997, Vol 3, Num 2, pp 91-99, issn 1368-4736Article

Classical multidrug resistance in acute myeloid leukaemiaPAIETTA, E.Medical oncology (Northwood). 1997, Vol 14, Num 1, pp 53-60, issn 1357-0560Article

Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRPSUGAWARA, I; AKIYAMA, S; SCHEPER, R. J et al.Cancer letters. 1997, Vol 112, Num 1, pp 23-31, issn 0304-3835Article

Multidrug resistance : molecular mechanisms and clinical relevanceLING, V.Cancer chemotherapy and pharmacology. 1997, Vol 40, pp S3-S8, issn 0344-5704, SUPConference Paper

Clinical trials of P-glycoprotein reversal in solid tumoursFERRY, D. R; TRAUNECKER, H; KERR, D. J et al.European journal of cancer (1990). 1996, Vol 32, Num 6, pp 1070-1081, issn 0959-8049Article

Pharmacological considerations in the modulation of multidrug resistanceFISHER, G. A; LUM, B. L; HAUSDORFF, J et al.European journal of cancer (1990). 1996, Vol 32, Num 6, pp 1082-1088, issn 0959-8049Article

P-glycoprotein : Its role in drug resistanceLING, V.The American journal of medicine. 1995, Vol 99, Num 6A, pp 6A.41-6A.34, issn 0002-9343Conference Paper

Transmembranous transport of drugs: Implications for kinetics and drug actionSTRATMANN, G; JAROSCH, A; SULZBACHER, A et al.International journal of clinical pharmacology and therapeutics. 1997, Vol 35, Num 4, pp 151-154, issn 0946-1965Conference Paper

Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in miceLANKAS, G. R; WISE, L. D; CARTWRIGHT, M. E et al.Reproductive toxicology (Elmsford, NY). 1998, Vol 12, Num 4, pp 457-463, issn 0890-6238Article

A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein geneVAN VEEN, H. W; CALLAGHAN, R; SOCENEANTU, L et al.Nature (London). 1998, Vol 391, Num 6664, pp 291-295, issn 0028-0836Article

Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistanceBRADSHAW, D. M; ARCECI, R. J.Journal of clinical oncology. 1998, Vol 16, Num 11, pp 3674-3690, issn 0732-183XArticle

Decreased expression and activity of P-glycoprotein in rat liver during acute inflammationPIQUETTE-MILLER, M; PAK, A; KIM, H et al.Pharmaceutical research. 1998, Vol 15, Num 5, pp 706-711, issn 0724-8741Article

Evaluation of the role of P-glycoprotein in ivermectin uptake by primary cultures of bovine brain microvessel endothelial cellsROSE, J. M; PECKHAM, S. L; SCISM, J. L et al.Neurochemical research. 1998, Vol 23, Num 2, pp 203-209, issn 0364-3190Article

Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cellsSAHA, P; YANG, J. J; LEE, V. H. L et al.Investigative ophthalmology & visual science. 1998, Vol 39, Num 7, pp 1221-1226, issn 0146-0404Article

Functional intracellular P-glycoproteinSHAPIRO, A. B; FOX, K; LEE, P et al.International journal of cancer. 1998, Vol 76, Num 6, pp 857-864, issn 0020-7136Article

Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolatesSEETHARAMAN, S; BARRAND, M. A; MASKELL, L et al.Journal of neurochemistry. 1998, Vol 70, Num 3, pp 1151-1159, issn 0022-3042Article

Clinical relevance of P-glycoprotein with respect to the application of resistance modifiersSCHEULEN, M. E.International journal of clinical pharmacology and therapeutics. 1998, Vol 36, Num 1, pp 41-45, issn 0946-1965Conference Paper

Acute myeloid leukemia cells with low P-glycoprotein expression and high rhodamine 123 efflux capacity display high clonogenicityDEMUR, C; MULLER, C; CASSAR, G et al.Leukemia. 1998, Vol 12, Num 2, pp 192-199, issn 0887-6924Conference Paper

Relative bioavailability of neoral versus sandimmune in the presence of a p450IIIA and P-glycoprotein inhibitorCHOC, M. G; MUELLER, E. A; ROBINSON, W. T et al.Transplantation proceedings. 1998, Vol 30, Num 5, pp 1664-1665, issn 0041-1345Conference Paper

Methods to detect P-glycoprotein and implications for other drug resistance-associated proteins : Phenotypic and genotypic analyses of multidrug resistance (MDR) in clinical hospital practiceBECK, W. T; GROGAN, T. M.Leukemia. 1997, Vol 11, Num 7, pp 1107-1109, issn 0887-6924Article

Molecular aspects of hepatobiliary transportMÜLLER, M; JANSEN, P. L. M.American journal of physiology. Gastrointestinal and liver physiology. 1997, Vol 35, Num 6, pp G1285-G1303, issn 0193-1857Article